PhagoMed
Vienna
About PhagoMed
PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.The company's platform is focused on the development of human therapeutic applications of phages and phage-derived proteins associated with urinary tract infections and bacterial vaginosis, enabling patients to get antibiotics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.4M
- Funding stage: M&A
- Last round: Seed (Jun 2019)
- Website: phagomed.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/phagomed-93679 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.